Enact Reports Third Quarter 2025 Results & Announces $0.21 per Share Quarterly Dividend

Rhea-AI Summary

Enact (Nasdaq: ACT) reported 3Q25 GAAP net income $163M or $1.10 diluted EPS and adjusted operating income $166M or $1.12 per diluted share. New insurance written was $14B (+6% QoQ) and primary insurance in-force was $272B (+2% YoY). PMIERs sufficiency was 162% (~$1.9B above requirement). The board declared a $0.21 quarterly dividend payable Dec 11, 2025 and raised 2025 capital return guidance to ~$500M.

Other items: ~2.8M shares repurchased in Q3 for ~$105M, Moody’s upgrade for EMICO, new $435M revolving credit facility, and reinsurance transactions ced­ing ~34% of 2027 NIW.

Positive

• Increased 2025 capital return guidance to approximately $500M
• Board declared quarterly dividend of $0.21 per share
• Repurchased ~2.8M shares for ~$105M in 3Q25
• New $435M five-year revolving credit facility secured
• NIW of $14B, up 6% sequentially
• Moody’s upgraded EMICO long-term ratings to Baa2/A2

Negative

• GAAP net income declined to $163M from $181M year‑ago
• PMIERs sufficiency fell to 162% (~$1.9B), down YoY
• Loss ratio rose to 15% from 5% in 3Q24
• Adjusted operating ROE declined to 12.6% from 14.8% YoY
• Net premiums earned decreased 2% year‑over‑year

Insights

Equity Analyst

Solid quarterly earnings, maintained capital discipline and raised capital-return guidance to ~$500 million.

Enact reported GAAP net income of $163 million (diluted $1.10 per share) and adjusted operating income of $166 million (adj. diluted $1.12), with return on equity at 12.4% and adjusted operating ROE at 12.6%. Core operating metrics remain stable: primary insurance in‑force reached $272 billion and new insurance written was $14 billion. The company also declared a quarterly dividend of $0.21 per share and increased full‑year capital return guidance to approximately $500 million, signaling a shareholder‑friendly capital posture.

Key dependencies and risks include loss‑ratio volatility and PMIERs headroom. Losses incurred rose to $36 million and the loss ratio moved to 15%, while PMIERs sufficiency narrowed to 162% (about $1.9 billion above requirement). Ratings upgrades for EMICO from Moody’s and positive outlooks from A.M. Best support capital flexibility but PMIERs trends and reserve developments remain the primary constraints on additional shareholder distributions.

Watch the announced dividend payable on December 11, 2025, the record date of November 21, 2025, the final 2025 capital return amount and form, and upcoming reserve and loss‑ratio disclosures over the next quarters. Near term (next 1–4 quarters), monitor PMIERs sufficiency, loss‑ratio trajectory, and the impact of ceded reinsurance covering ~34% of expected new insurance written for the 2027 book year on reported volatility.

GAAP Net Income of $163 million, or $1.10 per diluted share
Adjusted Operating Income of $166 million, or $1.12 per diluted share
Return on Equity of 12.4% and Adjusted Operating Return on Equity of 12.6%
Primary Insurance in-force of $272 billion, a 2% year-over-year increase
PMIERs Sufficiency of 162% or approximately $1.9 billion
Book Value Per Share of $36.53 and Book Value Per Share excluding AOCI of $36.82
Increased Full-Year Capital Return Guidance to approximately $500 million

RALEIGH, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) today announced financial results for the third quarter of 2025.

"Enact continues to execute with discipline and purpose,” stated Rohit Gupta, President and CEO of Enact. "We delivered another strong quarter, maintained our prudent approach to risk management and strong expense controls, and our performance positioned us to raise our capital returns target to its highest level since our IPO. Against the backdrop of an evolving housing market, we remain well positioned for success, with the proven strategy, financial flexibility and balance sheet strength to deliver and help more people responsibly achieve the dream of homeownership."

Key Financial Highlights

(In millions, except per share data or otherwise noted)	3Q25	2Q25	3Q24
Net Income (loss)	$163	$168	$181
Diluted Net Income (loss) per share	$1.10	$1.11	$1.15
Adjusted Operating Income (loss)	$166	$174	$182
Adj. Diluted Operating Income (loss) per share	$1.12	$1.15	$1.16
NIW ($B)	$14	$13	$14
Primary Persistency Rate	83%	82%	83%
Primary IIF ($B)	$272	$270	$268
Net Premiums Earned	$245	$245	$249
Losses Incurred	$36	$25	$12
Loss Ratio	15%	10%	5%
Operating Expenses	$53	$53	$56
Expense Ratio	22%	22%	22%
Net Investment Income	$69	$66	$61
Net Investment gains (losses)	$(3)	$(7)	$(1)
Return on Equity	12.4%	13.0%	14.7%
Adjusted Operating Return on Equity	12.6%	13.4%	14.8%
PMIERs Sufficiency ($)	$1,904	$1,961	$2,190
PMIERs Sufficiency (%)	162%	165%	173%

Third Quarter 2025 Financial and Operating Highlights

• Net income was $163 million, or $1.10 per diluted share, compared with $168 million, or $1.11 per diluted share, for the second quarter of 2025 and $181 million, or $1.15 per diluted share, for the third quarter of 2024. Adjusted operating income was $166 million, or $1.12 per diluted share, compared with $174 million, or $1.15 per diluted share, for the second quarter of 2025 and $182 million, or $1.16 per diluted share, for the third quarter of 2024.
• New insurance written (NIW) was $14 billion, up 6% from the second quarter of 2025, and up 3% from the third quarter of 2024. NIW for the current quarter was comprised of 97% monthly premium policies and 93% purchase originations.
• Persistency remained elevated at 83%, up from 82% in the second quarter of 2025 and flat to 83% in the third quarter of 2024. Approximately 21% of the mortgages in our portfolio had rates at least 50 basis points above September 2025’s average mortgage rate of 6.4%.
• Primary insurance in-force (IIF) was $272 billion, up approximately 1% from $270 billion in the second quarter of 2025 and up approximately 2% from $268 billion in the third quarter of 2024.
• Net premiums earned were $245 million, approximately flat from the second quarter of 2025 and down 2% from $249 million in the third quarter of 2024. The year-over-year decrease is primarily driven by higher ceded premiums.
• Losses incurred for the third quarter of 2025 were $36 million and the loss ratio was 15%, compared to $25 million and 10%, respectively, in the second quarter of 2025 and $12 million and 5%, respectively, in the third quarter of 2024. The current quarter’s reserve release of $45 million from favorable cure performance and loss mitigation activities compares to a reserve release of $48 million and $65 million in the second quarter of 2025 and third quarter of 2024, respectively.
• Operating expenses in the current quarter were $53 million, and the expense ratio was 22%. This is compared to $53 million and 22%, respectively, in the second quarter of 2025 and $56 million and 22%, respectively in the third quarter of 2024. The year-over-year decrease was primarily driven by continued prudent expense management.
• Net investment income was $69 million, up from $66 million in the second quarter of 2025 and up from $61 million in the third quarter of 2024, driven by the continuation of elevated interest rates and higher average invested assets.
• Net investment gains (losses) in the quarter were $(3) million, as compared to $(7) million sequentially and $(1) million in the same period last year. The activity is primarily driven by the identification of assets that upon selling allow us to recoup losses through higher net investment income.
• Annualized return on equity for the third quarter of 2025 was 12.4% and annualized adjusted operating return on equity was 12.6%. This compares to the second quarter of 2025 results of 13.0% and 13.4%, respectively, and to third quarter of 2024 results of 14.7% and 14.8%, respectively.
  
  

Capital and Liquidity

• We paid approximately $31 million, or $0.21 per share, dividend in the third quarter.
• EMICO completed a dividend of approximately $130 million in the third quarter that will primarily be used to support our ability to return capital to shareholders and bolster financial flexibility.
• Enact Holdings, Inc. held $339 million in cash and cash equivalents plus $311 million of invested assets as of September 30, 2025. Combined cash and invested assets is relatively flat from the prior quarter, primarily due to share buybacks, our quarterly dividend and offset by the contribution from EMICO.
• Moody’s Investor Service (“Moody’s”) upgraded the insurance financial strength rating for EMICO to A2 from A3 and upgraded the long-term issuer rating and senior unsecured debt rating to Baa2 from Baa3, the outlook for the ratings are stable.
• A.M. Best upgraded the financial strength rating outlook for EMICO, EHI and EMIC-NC to positive.
• We secured a quota share reinsurance transaction with a panel of highly-rated reinsurers that will cede approximately 34% of expected new insurance written for the 2027 book year.
• PMIERs sufficiency was 162% and $1.9 billion above the PMIERs requirements, compared to 165% and $2.0 billion above the PMIERs requirements in the second quarter of 2025.
  
  

Recent Events

• We repurchased approximately 2.8 million shares at an average price of $37.23 for a total of approximately $105 million in the quarter. Additionally, through October 31, 2025, we repurchased 1.2 million shares at an average price of $36.19 for a total of $42 million and approximately $146 million remain of our $350 million repurchase authorization.
• We announced that we have entered into a new $435 million five-year senior unsecured revolving credit facility that replaced the previous $200 million five-year senior unsecured revolving credit facility.
• Subsequent to quarter end, we announced an excess of loss reinsurance agreement with a panel of highly rated reinsurers that will provide approximately $170M of coverage on a portion of expected new insurance written for the 2027 book year.
• We announced today that the Board of Directors declared a quarterly dividend of $0.21 per share, payable on December 11, 2025, to shareholders of record on November 21, 2025.
• We now anticipate a total 2025 capital return of approximately $500 million recognizing our continued strong performance and current mortgage originations levels; the final amount and form of capital returned to shareholders will depend on business performance, market conditions, and regulatory approvals.
  
  

Conference Call and Financial Supplement Information
This press release, the third quarter 2025 financial supplement and earnings presentation are now posted on the Company’s website, https://ir.enactmi.com. Investors are encouraged to review these materials.

Enact will discuss third quarter financial results in a conference call tomorrow, Thursday, November 6, 2025, at 8:00 a.m. (Eastern). Participants interested in joining the call’s live question and answer session are required to pre-register by clicking here to obtain your dial-in number and unique PIN.   It is recommended to join at least 15 minutes in advance, although you may register ahead of the call and dial in at any time during the call.   If you wish to join the call but do not plan to ask questions, a live webcast of the event will be available on our website, https://ir.enactmi.com/news-and-events/events.

The webcast will also be archived on the Company’s website for one year.

About Enact
Enact (Nasdaq: ACT), operating principally through its wholly owned subsidiary Enact Mortgage Insurance Corporation since 1981, is a leading U.S. private mortgage insurance provider committed to helping more people achieve the dream of homeownership. Building on a deep understanding of lenders' businesses and a legacy of financial strength, we partner with lenders to bring best-in class service, leading underwriting expertise, and extensive risk and capital management to the mortgage process, helping to put more people in homes and keep them there. By empowering customers and their borrowers, Enact seeks to positively impact the lives of those in the communities in which it serves in a sustainable way. Enact is headquartered in Raleigh, North Carolina.

Safe Harbor Statement
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may address, among other things, our expected financial and operational results, the related assumptions underlying our expected results, guidance concerning the future return of capital and the quotations of management. These forward-looking statements are distinguished by use of words such as “will,” “may,” “would,” “anticipate,” “expect,” “believe,” “designed,” “plan,” “predict,” “project,” “target,” “could,” “should,” or “intend,” the negative of these terms, and similar references to future periods. These views involve risks and uncertainties that are difficult to predict and, accordingly, our actual results may differ materially from the results discussed in our forward-looking statements. Our forward-looking statements contained herein speak only as of the date of this press release. Factors or events that we cannot predict, including risks related to an economic downturn or a recession in the United States and in other countries around the world; changes in political, business, regulatory, and economic conditions; changes in or to Fannie Mae and Freddie Mac (the “GSEs”), whether through Federal legislation, restructurings or a shift in business practices; failure to continue to meet the mortgage insurer eligibility requirements of the GSEs; competition for customers; lenders or investors seeking alternatives to private mortgage insurance; an increase in the number of loans insured through Federal government mortgage insurance programs, including those offered by the Federal Housing Administration; and other factors described in the risk factors contained in our most recent Annual Report on Form 10-K and other filings with the SEC, may cause our actual results to differ from those expressed in forward-looking statements. Although Enact believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, Enact can give no assurance that its expectations will be achieved and it undertakes no obligation to update publicly any forward-looking statements as a result of new information, future events, or otherwise, except as required by applicable law.

GAAP/Non-GAAP Disclosure Discussion
This communication includes the non-GAAP financial measures entitled “adjusted operating income (loss),” “adjusted operating income (loss) per share," and “adjusted operating return on equity." Enact Holdings, Inc. (the “Company”) defines adjusted operating income (loss) as net income (loss) excluding the after-tax effects of net investment gains (losses), restructuring costs and infrequent or unusual non-operating items, and gain (loss) on the extinguishment of debt. The Company excludes net investment gains (losses), gains (losses) on the extinguishment of debt and infrequent or unusual non-operating items because the Company does not consider them to be related to the operating performance of the Company and other activities. The recognition of realized investment gains or losses can vary significantly across periods as the activity is highly discretionary based on the timing of individual securities sales due to such factors as market opportunities or exposure management. Trends in the profitability of our fundamental operating activities can be more clearly identified without the fluctuations of these realized gains and losses. We do not view them to be indicative of our fundamental operating activities. Therefore, these items are excluded from our calculation of adjusted operating income. In addition, adjusted operating income (loss) per share is derived from adjusted operating income (loss) divided by shares outstanding. Adjusted operating return on equity is calculated as annualized adjusted operating income for the period indicated divided by the average of current period and prior periods’ ending total stockholders’ equity.

While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, the Company believes that adjusted operating income (loss) and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis and adjusted operating return on equity, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) available to Enact Holdings, Inc.’s common stockholders or net income (loss) available to Enact Holdings, Inc.’s common stockholders per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, the Company’s definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) available to Enact Holdings, Inc.’s common stockholders to adjusted operating income (loss) assume a 21% tax rate.

The tables at the end of this press release provide a reconciliation of net income (loss) to adjusted operating income (loss) and U.S. GAAP return on equity to adjusted operating return on equity for the three months ended September 30, 2025 and 2024, as well as for the three months ended June 30, 2025.

Exhibit A: Consolidated Statements of Income (amounts in thousands, except per share amounts)

	3Q25			2Q25			3Q24
REVENUES:
Premiums	$244,688			$245,289			$249,055
Net investment income		68,611			65,884			61,056
Net investment gains (losses)		(2,834	)		(7,343	)		(1,243	)
Other income		990			1,060			720
Total revenues		311,455			304,890			309,588
LOSSES AND EXPENSES:
Losses incurred		35,885			25,289			12,164
Acquisition and operating expenses, net of deferrals		50,500			50,598			53,091
Amortization of deferred acquisition costs and intangibles		2,344			2,205			2,586
Interest expense		12,897			12,296			12,290
Total losses and expenses		101,626			90,388			80,131
INCOME BEFORE INCOME TAXES		209,829			214,502			229,457
Provision for income taxes		46,332			46,694			48,788
NET INCOME	$163,497			$167,808			$180,669
Net investment (gains) losses		2,834			7,343			1,243
Costs associated with reorganization		189			(24	)		848
Loss on debt extinguishment		0			0			0
Taxes on adjustments		(635	)		(1,537	)		(439	)
Adjusted Operating Income	$165,885			$173,590			$182,321
Loss ratio(1)		15	%		10	%		5	%
Expense ratio(2)		22	%		22	%		22	%
Earnings Per Share Data:
Net Income per share
Basic	$1.11			$1.12			$1.16
Diluted	$1.10			$1.11			$1.15
Adj operating income per share
Basic	$1.13			$1.16			$1.17
Diluted	$1.12			$1.15			$1.16
Weighted-average common shares outstanding
Basic		147,434			149,940			155,561
Diluted		148,340			150,729			157,016
(1)The ratio of losses incurred to net earned premiums.
(2)The ratio of acquisition and operating expenses, net of deferrals, and amortization of deferred acquisition costs and intangibles to net earned premiums. Expenses associated with strategic transaction preparations and restructuring costs increased the expense ratio by zero percentage points for the three-month periods ended September 30, 2025, June 30, 2025, and September 30, 2024.

Exhibit B: Consolidated Balance Sheets (amounts in thousands, except per share amounts)

Assets	3Q25			2Q25			3Q24
Investments:
Fixed maturity securities available-for-sale, at fair value	$6,068,501			$5,896,818			$5,652,399
Short term investments		2,002			3,001			1,550
Total investments		6,070,503			5,899,819			5,653,949
Cash and cash equivalents		543,577			612,967			673,363
Accrued investment income		53,895			53,259			45,954
Deferred acquisition costs		22,521			22,910			24,160
Premiums receivable		48,648			44,091			48,834
Other assets		114,114			107,882			100,723
Deferred tax asset		23,185			32,545			50,063
Total assets	$6,876,443			$6,773,473			$6,597,046
Liabilities and Shareholders' Equity
Liabilities:
Loss reserves	$572,054			$551,940			$510,401
Unearned premiums		96,031			101,205			121,382
Other liabilities		146,958			153,447			186,312
Long-term borrowings		744,114			743,753			742,706
Total liabilities		1,559,157			1,550,345			1,560,801
Equity:
Common stock		1,456			1,484			1,544
Additional paid-in capital		1,826,764			1,927,372			2,145,518
Accumulated other comprehensive income		(41,785	)		(104,342	)		(101,984	)
Retained earnings		3,530,851			3,398,614			2,991,167
Total equity		5,317,286			5,223,128			5,036,245
Total liabilities and equity	$6,876,443			$6,773,473			$6,597,046
Book value per share	$36.53			$35.20			$32.61
Book value per share excluding AOCI	$36.82			$35.90			$33.27
U.S. GAAP ROE(1)		12.4	%		13.0	%		14.7	%
Net investment (gains) losses		0.2	%		0.6	%		0.1	%
Costs associated with reorganization		0.0	%		0.0	%		0.1	%
(Gains) losses on early extinguishment of debt		0.0	%		0.0	%		0.0	%
Taxes on adjustments		0.0	%	(0.1)        %				0.0	%
Adjusted Operating ROE(2)		12.6	%		13.4	%		14.8	%
Debt to Capital Ratio		12	%		12	%		13	%
(1)Calculated as annualized net income for the period indicated divided by the average of current period and prior periods’ ending total stockholders’ equity
(2)Calculated as annualized adjusted operating income for the period indicated divided by the average of current period and prior periods’ ending total stockholders’ equity

This press release was published by a CLEAR® Verified individual.

Investor Contact
Daniel Kohl
EnactIR@enactmi.com

Media Contact
Sarah Wentz
Sarah.Wentz@enactmi.com

FAQ

What were Enact (ACT) 3Q25 GAAP earnings and EPS?

Enact reported GAAP net income $163M, or $1.10 diluted EPS for 3Q25.

How much dividend did Enact (ACT) declare for the quarter and when is payment?

The board declared a $0.21 per share quarterly dividend payable on Dec 11, 2025 to shareholders of record on Nov 21, 2025.

What is Enact’s updated 2025 capital return guidance for ACT?

Enact raised its full‑year capital return guidance to approximately $500M for 2025.

How much new insurance written (NIW) did Enact (ACT) report in 3Q25?

Enact reported $14 billion of NIW in 3Q25, up 6% versus 2Q25.

What happened to Enact’s PMIERs sufficiency and why does it matter for ACT?

PMIERs sufficiency was 162% (~$1.9B above requirement); it measures regulatory capital buffer for mortgage insurance operations.

Did Enact (ACT) repurchase shares in 3Q25 and how much remains authorized?

Yes — repurchased ~2.8M shares for $105M in 3Q25; ~$146M remains under the $350M authorization.

Were there any rating or financing updates for Enact (ACT) in 3Q25?

Moody’s upgraded EMICO to A2 (long‑term issuer Baa2) and Enact secured a new $435M revolving credit facility.